Grown Rogue International (GRUSF) Other financing activities (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Other financing activities came in at $21839.0 in Q1 2026, up 36.17% year-on-year from $16038.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$405.9 billion in Q4 2025.
Grown Rogue International (GRUSF) Other financing activities (2009 - 2026) Analysis & Trends
Grown Rogue International's Other financing activities history runs 14 years deep, the most recent figure standing at $21839.0 for Q1 2026.
- On a quarterly basis, Other financing activities rose 36.17% year-over-year to $21839.0 in Q1 2026; TTM through Mar 2026 was $412745.0, a 1396.11% increase from a year earlier, with the FY2025 full-year figure at $406944.0, down 91.17% from the prior year.
- Other financing activities climbed to $21839.0 in Q1 2026 per GRUSF's latest filing, from -$405.9 billion in the prior quarter.
- Across five years, Other financing activities topped out at $405.9 billion in Q3 2025 and bottomed at -$405.9 billion in Q4 2025.
- The 4-year median for Other financing activities is $205833.5 (2025), against an average of $633836.0.
- Across the five-year window, Other financing activities jumped 550.0% in 2022 and plunged 99.66% in 2025, its largest moves.
- Year by year, Other financing activities stood at $1.3 million in 2022, then slumped by 27688822.34% to -$360.0 billion in 2024, then retreated by 12.76% to -$405.9 billion in 2025, then soared by 100.0% to $21839.0 in 2026.
- Per Business Quant, the three latest GRUSF Other financing activities figures stand at $21839.0 (Q1 2026), -$405.9 billion (Q4 2025), and $405.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,839.00 |
| Mar 31, 2026 | 21,839.00 |
| Dec 31, 2025 | -405.87 Bn |
| Dec 31, 2025 | -405.87 Bn |
| Sep 30, 2025 | 405.87 Bn |
| Sep 30, 2025 | 405.87 Bn |
| Jun 30, 2025 | 389,828.00 |
| Jun 30, 2025 | 389,828.00 |
| Mar 31, 2025 | 16,038.00 |
| Mar 31, 2025 | 16,038.00 |
| Dec 31, 2024 | -359.95 Bn |
| Dec 31, 2024 | -359.95 Bn |
| Sep 30, 2024 | 359.96 Bn |
| Sep 30, 2024 | 359.96 Bn |
| Jun 30, 2024 | -4.46 Mn |
| Jun 30, 2024 | -4.46 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Jan 31, 2022 | 1.30 Mn |
| Jan 31, 2022 | 1.30 Mn |